|
Innovative therapeutic interventions against Idiopathic Pulmonary Fibrosis IN CORSO Tipologia: PRIN 2022 Responsabile: Francesca Bianchini |
|
Head and neck paragangliomas: histopathological, genetic and clinical correlation IN CORSO Tipologia: PRIN 2022 Responsabile: Letizia Canu |
|
Decoding distinctive features of EXtracellular vesicles In TDP-43 proteinopathies – EXIT IN CORSO Tipologia: PRIN 2022 Responsabile: Roberta Cascella |
|
Insight into the molecular mechanisms of pulmonary fibrosis: IN CORSO new targets to control the switch from fibrotic to regenerative fibroblast phenotype - SMILE Tipologia: PRIN 2022 Responsabile: Francesca Cencetti |
|
Immunological TArgeting of CAncer cells through Mvs-mediated tagging IN CORSO Tipologia: PRIN 2022 Responsabile: Paolo Cirri |
|
Identification of novel molecular mechanisms affecting spermatogenesis, IN CORSO sperm maturation and epigenetic signature in obesity-related male infertility Tipologia: PRIN 2022 Responsabile Chiara Donati |
|
Metabolic alterations and immune escape in IN CORSO colorectal cancer: "activity metabolomics" as a novel therapeutic approach Tipologia: PRIN 2022 Responsabile: Elisa Giannoni |
|
Chemotherapy exposure of testicular cancer survivors: IN CORSO study of genetic and epigenetic alterations in spermatozoa Tipologia: PRIN 2022 Responsabile: Csilla Gabriella Krausz |
|
Tubular epithelial cell polyploidy in MYH9-related disease nephropathy IN CORSO Tipologia: PRIN 2022 Responsabile: Elena Lazzeri |
|
Characterizing the role of CD300e receptor in obesity: IN CORSO low-grade inflammation, insulin-resistance and immunomodulatory properties Tipologia: PRIN 2022 Responsabile: Francesco Lolli |
|
Integrating cutting-edge tools for targeted approach to IN CORSO patients with adrenocortical tumors (COOL-REACT) Tipologia: PRIN 2022 Responsabile: Michaela Luconi |
|
The role of maternal hemodynamics in therapy of hypertensive IN CORSO disease of pregnancy: a randomized controlled trial Tipologia: PRIN 2022 Responsabile: Federico Mecacci |
|
Is NRF2-driven metabolic reprogramming a unique IN CORSO feature of cancer cells? A study on normal, preneoplastic and neoplastic hepatocytes. Tipologia: PRIN 2022 Responsabile: Andrea Morandi |
|
Advanced Lung Phantom based on Hierarchical IN CORSO mAterials for multimodal theranostics (ALPHA) Tipologia: PRIN 2022 Responsabile: Stefania Pallotta |
|
Design and building of a setup for the detection of beta IN CORSO emitter contaminants in radiopharmaceutical drugs in medical diagnostics Tipologia: PRIN 2022 Responsabile: Alessandro Passeri |
|
Sensing kidney damage and tumor trasformation piezoelectric nanowebs IN CORSO Tipologia: PRIN 2022 Responsabile: Paola Romagnani |
|
InTrEPID: In vivo 3D dosimetry in radiotherapy Treatments with EPID IN CORSO Tipologia: PRIN 2022 Responsabile: Cinzia Talamonti |
Ultimo aggiornamento
09.07.2024